# University Of Central Arkansas Uark #IFB11162026

Automated solid-phase peptide synthesizer for University of Arkansas biomedical engineering research

**Posted:** November 17, 2026
**Respond By:** December 04, 2026
**Identifier:** IFB11162026
**NAICS:** 334516

The University of Arkansas is seeking an automated peptide synthesizer for biomedical engineering research.
- **Government buyer:** University of Arkansas, Fayetteville, Office of Business Affairs/Office of Procurement; Hwang Research Laboratory, Department of Biomedical Engineering, College of Engineering.
- **OEM/reference model:** **CEM — Liberty Blue 2.0**. Equivalent systems may be proposed with documentation showing they meet the requirements.
- **Product:** One fully automated solid-phase peptide synthesizer, including a PC, software, and starter reagent and amino-acid kits.
- **Key requirements:** Controlled microwave heating from at least 25–110°C; four or more isolated reagent paths; support for common SPPS coupling chemistries, including DIC/Oxyma-based CarboMAX; synthesis across at least 5 μmol to 5 mmol using no more than two vessel sizes; and an upgrade path for a queue of at least 12 peptides. The system should support fast compatible cycles, avoid resin washing, use headspace flushing during deprotection, and produce less than 8 mL of waste per cycle at 0.1 mmol scale.
- **Services and support:** Shipping, installation, system testing and verification, and initial user training. A minimum two-year warranty is required.
- **Term and delivery:** Initial four-year contract term with three optional renewal years. In-stock equipment is required within 30 days after receipt of the purchase order; specialty items with longer standard lead times are exempt from that limit.

### Description

The University of Arkansas is seeking bids for the purchase, delivery, installation, and commissioning of a fully automated solid-phase peptide synthesizer for the Hwang Research Laboratory in the Department of Biomedical Engineering. The instrument will support research-scale synthesis of diverse peptide sequences and modifications, including peptides used in biomaterials, nanomaterials, therapeutic delivery, and related biomedical research. Bids are due December 4, 2026, at 2:30 p.m. CST, and must be submitted through UA Formal Bid Submission.

[View original listing](https://hogbid.uark.edu/index.php)
